Rho Kinase Inhibition: A New Approach for Treating Diabetic Nephropathy?
Author:
Affiliation:
1. From the Monash University Department of Medicine and Department of Endocrinology and Diabetes, Alfred Hospital, Melbourne, Victoria, Australia
Publisher
American Diabetes Association
Subject
Endocrinology, Diabetes and Metabolism,Internal Medicine
Link
https://journals.org/diabetes/diabetes/article-pdf/57/3/532/390123/zdb00308000532.pdf
Reference12 articles.
1. Vega FM, Ridley AJ: SnapShot: Rho family GTPases. Cell 129:1430,2007
2. Hayashi K, Wakino S, Kanda T, Homma K, Sugano N, Saruta T: Molecular mechanisms and therapeutic strategies of chronic renal injury: role of rho-kinase in the development of renal injury. J Pharmacol Sci 100:29–33,2006
3. Budzyn K, Marley PD, Sobey CG: Targeting Rho and Rho-kinase in the treatment of cardiovascular disease. Trends Pharmacol Sci 27:97–104,2006
4. Sharpe CC, Hendry BM: Signaling: focus on Rho in renal disease. J Am Soc Nephrol 14:261–264,2003
5. Massey AR, Miao L, Smith BN, Liu J, Kusaka I, Zhang JH, Tang J: Increased RhoA translocation in renal cortex of diabetic rats. Life Sci 72:2943–2952,2003
Cited by 22 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Evaluation of Cardiac Autonomic Dysfunctions in Children with Type 1 Diabetes Mellitus;2023-11-03
2. A Compressive Review on Novel Molecular Target of Diabetic Nephropathy;Research Journal of Pharmacy and Technology;2022-03-24
3. Inhibition of Retinal Ganglion Cell Loss By a Novel ROCK Inhibitor (E212) in Ischemic Optic Nerve Injury Via Antioxidative and Anti-Inflammatory Actions;Investigative Opthalmology & Visual Science;2021-05-20
4. Increased dishevelled associated activator of morphogenesis 2, a new podocyte-associated protein, in diabetic nephropathy;Nephrology Dialysis Transplantation;2021-02-05
5. Vascular dysfunction in obese diabetic db/db mice involves the interplay between aldosterone/mineralocorticoid receptor and Rho kinase signaling;Scientific Reports;2018-02-13
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3